| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/18/2006 | US7078402 Sulfur compounds such as S-methyl 4-dimethylamino-4-methyl-2-pentynethioate, used for prophylaxis of cancers, skin disorders or vision defects |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078178 Identifying modulators of transmembrane calcium transfer; for treating bone, cancer and blood disorders |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078059 Treatment of bone diseases |
| 07/18/2006 | US7078040 Administering to animal or man of at least one type of xanthophyll in an amount inhibiting the expression of inflammatory cytokines and chemokines in animal or man |
| 07/18/2006 | CA2364864C New metalloprotease inhibitors, the procedure for preparing them and the pharmaceutical compounds containing them |
| 07/18/2006 | CA2216592C Benzothiophene compounds, intermediates, compositions, and methods |
| 07/13/2006 | WO2006073197A1 1-thio-d-glucitol derivatives |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072623A1 Local treatment of bone defects with matrix releasing bmp or pth |
| 07/13/2006 | WO2006057011A3 Use of chitosan for stimulating bone healing and bone formation |
| 07/13/2006 | WO2006034956A3 Osteogenic oligonucleotides and uses thereof |
| 07/13/2006 | WO2006004833A3 Pyrrolotriazine kinase inhibitors |
| 07/13/2006 | WO2005113012A3 Beta adrenergic drug conjugated to bone targeting moiety for modulating bone mass |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154972 Amino acids with affinity for the alpha-2-delta-protein |
| 07/13/2006 | US20060154966 Novel raloxifene acid additon salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these |
| 07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 07/13/2006 | US20060154920 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij] quinoline derivatives as antipsychotic and antiobesity agents |
| 07/13/2006 | US20060154907 Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 07/13/2006 | US20060154905 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 07/13/2006 | US20060154900 Diphosphonate solutions |
| 07/13/2006 | US20060154898 Diphosphonate solutions |
| 07/13/2006 | US20060153893 Therapeutic composition for bone infectious disease |
| 07/13/2006 | US20060153884 can be associated with the peptide 111-136 of HARP; cancer treatment |
| 07/13/2006 | US20060153770 Method of treating tumors |
| 07/13/2006 | US20060151899 Process for producing drug ultramicroparticle and apparatus therefor |
| 07/13/2006 | DE102004063494A1 Antikörper Antibody |
| 07/13/2006 | CA2744999A1 Regimens for intra-articular viscosupplementation |
| 07/13/2006 | CA2592877A1 Local treatment of bone defects with matrix releasing bmp or pth |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1678156A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 07/12/2006 | EP1678124A1 Novel molecules to develop drug for the treatment of osteoporosis |
| 07/12/2006 | EP1677806A1 Methods for treating acute and overuse sprain and strain using hyaluronic acid |
| 07/12/2006 | EP1677787A1 Combinations of potassium channel openers and sodium channel inhibitors or active substances influencing sodium channels in order to treat painful conditions |
| 07/12/2006 | EP1677782A2 Inhibitors of cathepsin s |
| 07/12/2006 | EP1677768A2 Extended release formulations of opioids and method of use thereof |
| 07/12/2006 | EP1677627A1 Dietetic preparation with hyaluronate for treatment of osteoporosis |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | EP1436321B1 Synthesis of cyclosporin analogs |
| 07/12/2006 | EP1427732B1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a|pyrazol-1-ones which control inflammatory cytokines |
| 07/12/2006 | EP1392311B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | EP1071764B1 Antisense oligonucleotides for the inhibition of integrin alphav-subunit expression |
| 07/12/2006 | CN1802357A Aminopyrimidine derivatives and their medical use |
| 07/12/2006 | CN1802172A Therapeutic composition for autoimmune conditions |
| 07/12/2006 | CN1802166A Compositions for mucosal and oral administration comprising HCG fragments |
| 07/12/2006 | CN1800164A Kukoline C ring modified derivative and its synthesis method |
| 07/12/2006 | CN1799623A Use of No. 21 biological active peptide in preparation of medicine for preventing and treating arthritis |
| 07/12/2006 | CN1799619A Chinese medicinal gel formulation and its preparing process |
| 07/12/2006 | CN1799610A Bone-strengthening herbal medicinal wine and its preparation method |
| 07/12/2006 | CN1799604A Calcium-tonifying bone-strengthening medicine and preparation method thereof |
| 07/12/2006 | CN1799603A Chinese traditional medicine composition for treating rheumatic or rheumatoid disease and preparation method thereof |
| 07/12/2006 | CN1799600A Ointment for treating swelling and pain by traumatic injury and preparation process thereof |
| 07/12/2006 | CN1799599A Medicine for treating joint disease |
| 07/12/2006 | CN1799583A Medicine for treating cervical disease and its preparation method |
| 07/12/2006 | CN1799572A Method for extracting biological active substances from bean embryo and its application |
| 07/12/2006 | CN1799548A Soybean isoflavone phospholipid composition and preparation method thereof |
| 07/12/2006 | CN1799541A Soybean isoflavone soft capsule and its preparation process |
| 07/12/2006 | CN1263852C Extracellular matrix signalling molecules |
| 07/12/2006 | CN1263771C Preparing method and use for osteoprotegerin fusion protein |
| 07/12/2006 | CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives |
| 07/12/2006 | CN1263733C Substituted phenyl derivatives, their preparation and use |
| 07/12/2006 | CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels |
| 07/12/2006 | CN1263720C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 07/12/2006 | CN1263500C Chinese medicine for treating cervical spondylopathy and preparation method thereof |
| 07/12/2006 | CN1263498C Medicine for treating arthraligia caused by wind, cold and wetness evils and with weight-reducing function and its preparing method |
| 07/12/2006 | CN1263496C Medicine for treating cervical vertebra disease and its preparing process |
| 07/12/2006 | CN1263475C Toxicant-expelling and injuries-treating ointment |
| 07/11/2006 | US7074939 Indole derivatives as anti-inflammatory agents |
| 07/11/2006 | US7074930 Amine salts of an integrin receptor antagonist |
| 07/11/2006 | US7074896 Gene expression of nucleic acid in prokaryotic cells; homogeneity, purity; immobilization; separation of antibodies by chromatography |
| 07/11/2006 | US7074816 Gout; xanthine oxidase inhibitors; reacting iminoether or an aromatic nitrile with hydrazide |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074802 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
| 07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074790 Antiinflammatory agents; autoimmune disease |
| 07/11/2006 | US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
| 07/11/2006 | US7074435 Crude drug compositions for treating or preventing arthritic diseases and the preparation process |
| 07/11/2006 | US7074412 For therapy of orthopaedic and dental, including periodontal, diseases |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2341375C Extended release buccal bioadhesive tablet |
| 07/11/2006 | CA2319201C Celecoxib compositions |
| 07/11/2006 | CA2285548C Nicotinamide derivatives |
| 07/11/2006 | CA2283829C 2-alkylidene-19-nor-vitamin d compounds |
| 07/11/2006 | CA2262566C Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
| 07/06/2006 | WO2006070943A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006070726A1 N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same |
| 07/06/2006 | WO2006050314A3 Once a day formulation for phosphate binders |
| 07/06/2006 | WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/06/2006 | US20060149075 Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione |
| 07/06/2006 | US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |